Japan BioPharma Equity Research Associate (Bernstein - Tokyo)

We are looking for Research Associates with Finance and Biology / BioPharma experience, as well as Japanese and English language skills to join our Tokyo office of Bernstein’s premier Equity Research platform. The Japan Biopharma team comprises of a small number of professionals, and you will have a high level of responsibility and be empowered to make an important contribution. These are typically 3-5 year positions with outstanding growth potential. Historically, our associate positions have proven to be excellent platforms for successful professional careers in investing.

Principal Responsibilities:

• Acquire expertise in Japan Biopharma companies working with a Senior Analyst who is a seasoned industry expert
• Become highly proficient at in-depth analysis of Biopharma and Healthcare themes, companies, and stocks
• Author highly differentiated written research that is famous for its deep industry insights and quantitative frameworks, including our signature Blackbook product
• Become adept at financial modeling, including building detailed forward-looking earning models
• Build strong relationships across the investing community, including our sales and trading teams and institutional clients 
• Build a network within your industry, including senior managements of your companies and industry contacts

Eligibility:

• Relevant bachelor/master’s degree holders in Biology, Healthcare, Business, and Finance
• Able to start working immediately or up too 3 months notice
• Experienced professionals may be considered as Senior Research Associates

About You:

• Excellent broad-based analytical skills
• Outstanding verbal and written communication skills
• Strong intellectual curiosity and passionate about equity research
• Organic leadership and an entrepreneurial mindset

Language Skills:

• English: Business level
• Japanese: Native level or Level 1 JLPT

Business Insight

Bernstein is widely recognized as a premier global equity research and brokerage firm, with a trading platform that spans the US, Europe, and Asia. Our research and trading capabilities are sought out by leading investment managers around the world, and we have a long history of our research receiving #1 rankings for overall quality and industry knowledge.

Research is our legacy and foundation. Our brand is defined by our Black books, renowned for their in-depth quantitative forecasts and unmatched industry expertise. Our Research Analysts are thought leaders who typically have many years of direct experience in the industries they cover. Our reputation is for the very highest caliber of disciplined investment and industry analysis.

In 2019 Bernstein acquired Autonomous Research, a highly regarded global financial services independent research firm. This acquisition further strengthened us as the preeminent provider of the highest-quality research to our clients worldwide.

On April 1, 2024, Alliance Bernstein and Societe Generale announced the official launch of Bernstein, a new joint venture expanding our global cash equities and equity research business. Clients now have unparalleled equity liquidity access and a full range of integrated services, leveraging Bernstein’s cash equities and research capabilities and Societe Generale’s equity derivatives, prime services and equity capital markets offering.